Martine C. Maculaitis

ORCID: 0000-0001-8388-5315 · 5 papers in corpus
observational 2025
Women's health (London, England) ·doi:10.1177/17455057251331700

BACKGROUND: Endometriosis symptoms have multifaceted manifestations, and there are few approved nonsurgical treatment options. Gonadotropin-releasing hormone (GnRH) agonists/antagonists for endometriosis vary on efficacy, safety profile, an…

other 2025
Women's health (London, England) ·doi:10.1177/17455057241311765

BACKGROUND: Previous research has identified treatment attributes and outcomes for endometriosis patients, highlighting the need for tailored interventions to improve patient care. These studies emphasize the need to understand patient expe…

observational 2023
Journal of managed care & specialty pharmacy ·doi:10.18553/jmcp.2023.29.2.197

BACKGROUND: Migraine is the second most common cause of disability worldwide. Understanding the relationship between migraine and employment status is critical for policymakers, as disability-related unemployment is associated with eligibil…

observational 2022
·doi:10.1093/humrep/deac107.300

Abstract Study question Beyond reducing pain, how do women with moderate-severe-endometriosis pain prioritize treatment features and outcomes associated with gonadotropin-releasing hormone (GnRH) analogues? Summary answer Moderate-severe-en…

2022
·doi:10.1016/j.jval.2022.09.2224